Skip to main content
SpringerLink
Log in
Book cover

Antiphospholipid Syndrome pp 235–246Cite as

Task Force Report on Non-criteria Manifestations: Skin

  • Chapter
  • First Online:

  • 631 Accesses

Abstract

Many cutaneous manifestations have been described in patients with antiphospholipid syndrome, including livedo reticularis and racemosa, atrophie blanche, livedoid vasculopathy, skin ulcerations and necrosis, anetoderma, and malignant atrophic papulosis. This chapter reviews the definition, biopsy findings, and management of these cutaneous manifestations that can occur in patients with antiphospholipid antibodies.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Shoenfeld Y. APS—more systemic disease than SLE. Clin Rev Allergy Immunol. 2007;32:129–30.

    Article  PubMed  Google Scholar 

  2. Espinosa G, Cervera R, Font J, et al. Antiphospholipid syndrome: pathogenic mechanisms. Autoimmun Rev. 2003;2:86–93.

    Article  PubMed  Google Scholar 

  3. Asherson RA, Cervera R. Microvascular and microangiopathic antiphospholipid-associated syndromes (“MAPS”): semantic or antisemantic? Autoimmun Rev. 2008;7:164–7.

    Article  PubMed  CAS  Google Scholar 

  4. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295–306.

    Article  PubMed  CAS  Google Scholar 

  5. Frances C, Niang S, Laffitte E, et al. Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases. Arthritis Rheum. 2005;52:1785–93.

    Article  PubMed  Google Scholar 

  6. Alegre VA, Gastineau DA, Winkelmann RK. Skin lesions associated with circulating lupus anticoagulant. Br J Dermatol. 1989;120:419–29.

    Article  PubMed  CAS  Google Scholar 

  7. Gibson GE, Su WP, Pittelkow MR. Antiphospholipid syndrome and the skin. J Am Acad Dermatol. 1997;36:970–82.

    Article  PubMed  CAS  Google Scholar 

  8. Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46:1019–27.

    Article  PubMed  Google Scholar 

  9. Hughes GR. Hughes syndrome—the syndrome behind the name (otherwise known as antiphospholipid syndrome). Isr Med Assoc J. 1999;1:100–3.

    PubMed  CAS  Google Scholar 

  10. Kester S, McCarty DL, McCarty GA. The antiphospholipid antibody syndrome in the emergency department setting—livedo reticularis and recurrent venous thrombosis. Ann Emerg Med. 1992;21:207–11.

    Article  PubMed  CAS  Google Scholar 

  11. Toubi E, Krause I, Fraser A, et al. Livedo reticularis is a marker for predicting multi-system thrombosis in antiphospholipid syndrome. Clin Exp Rheumatol. 2005;23:499–504.

    PubMed  CAS  Google Scholar 

  12. Asherson RA, Mayou SC, Merry P, et al. The spectrum of livedo reticularis and anticardiolipin antibodies. Br J Dermatol. 1989;120:215–21.

    Article  PubMed  CAS  Google Scholar 

  13. Weinstein S, Piette W. Cutaneous manifestations of antiphospholipid antibody syndrome. Hematol Oncol Clin North Am. 2008;22:67–77. vi.

    Article  PubMed  Google Scholar 

  14. Diogenes MJ, Diogenes PC, de Morais Carneiro RM, et al. Cutaneous manifestations associated with antiphospholipid antibodies. Int J Dermatol. 2004;43:632–7.

    Article  PubMed  CAS  Google Scholar 

  15. Biggioggero M, Meroni PL. The geoepidemiology of the antiphospholipid antibody syndrome. Autoimmun Rev. 2010;9:A299–304.

    Article  PubMed  Google Scholar 

  16. Naldi L, Locati F, Marchesi L, et al. Cutaneous manifestations associated with antiphospholipid antibodies in patients with suspected primary antiphospholipid syndrome: a case–control study. Ann Rheum Dis. 1993;52:219–22.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  17. Sebastiani GD, Galeazzi M, Tincani A, et al. Anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. European Concerted Action on the Immunogenetics of SLE. Scand J Rheumatol. 1999;28:344–51.

    Article  PubMed  CAS  Google Scholar 

  18. Vlachoyiannopoulos PG, Krilis SA, Hunt JE, et al. Patients with anticardiolipin antibodies with and without antiphospholipid syndrome: their clinical features and beta 2-glycoprotein-I plasma levels. Eur J Clin Invest. 1992;22:482–7.

    Article  PubMed  CAS  Google Scholar 

  19. Frances C, Papo T, Wechsler B, et al. Sneddon syndrome with or without antiphospholipid antibodies. A comparative study in 46 patients. Medicine (Baltimore). 1999;78:209–19.

    Article  CAS  Google Scholar 

  20. Hughes GR, Khamashta MA. Seronegative antiphospholipid syndrome. Ann Rheum Dis. 2003;62:1127.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  21. Sangle S, D’Cruz DP, Hughes GR. Livedo reticularis and pregnancy morbidity in patients negative for antiphospholipid antibodies. Ann Rheum Dis. 2005;64:147–8.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  22. Pelajo CF, Lopez-Benitez JM, Miller LC. Vitamin D and autoimmune rheumatologic disorders. Autoimmun Rev. 2010;9:507–10.

    Article  PubMed  CAS  Google Scholar 

  23. Gibbs MB, English 3rd JC, Zirwas MJ. Livedo reticularis: an update. J Am Acad Dermatol. 2005;52:1009–19.

    Article  PubMed  Google Scholar 

  24. Erkan D, Harrison MJ, Levy R, et al. Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis Rheum. 2007;56:2382–91.

    Article  PubMed  CAS  Google Scholar 

  25. Khamashta MA. Primary prevention of thrombosis in subjects with positive antiphospholipid antibodies. J Autoimmun. 2000;15:249–53.

    Article  PubMed  CAS  Google Scholar 

  26. Devos J, Bulcke J, Degreef H, et al. Sneddon’s syndrome: generalized livedo reticularis and cerebrovascular disease. Importance of hemostatic screening. Dermatology. 1992;185:296–9.

    Article  PubMed  CAS  Google Scholar 

  27. Sneddon IB. Cerebro-vascular lesions and livedo reticularis. Br J Dermatol. 1965;77:180–5.

    Article  PubMed  CAS  Google Scholar 

  28. Kraemer M, Linden D, Berlit P. The spectrum of differential diagnosis in neurological patients with livedo reticularis and livedo racemosa. A literature review. J Neurol. 2005;252:1155–66.

    Article  PubMed  Google Scholar 

  29. Zelger B, Sepp N, Stockhammer G, et al. Sneddon’s syndrome. A long-term follow-up of 21 patients. Arch Dermatol. 1993;129:437–47.

    Article  PubMed  CAS  Google Scholar 

  30. Acland KM, Darvay A, Wakelin SH, et al. Livedoid vasculitis: a manifestation of the antiphospholipid syndrome? Br J Dermatol. 1999;140:131–5.

    Article  PubMed  CAS  Google Scholar 

  31. Hairston BR, Davis MD, Pittelkow MR, et al. Livedoid vasculopathy: further evidence for procoagulant pathogenesis. Arch Dermatol. 2006;142:1413–8.

    Article  PubMed  Google Scholar 

  32. Khenifer S, Thomas L, Balme B, et al. Livedoid vasculopathy: thrombotic or inflammatory disease? Clin Exp Dermatol. 2009;35:693–8.

    Article  Google Scholar 

  33. Klein KL, Pittelkow MR. Tissue plasminogen activator for treatment of livedoid vasculitis. Mayo Clin Proc. 1992;67:923–33.

    Article  PubMed  CAS  Google Scholar 

  34. Criado PR, Rivitti EA, Sotto MN, et al. Livedoid vasculopathy as a coagulation disorder. Autoimmun Rev. 2011;10:353–60.

    Article  PubMed  Google Scholar 

  35. Rossini J, Roverano S, Graf C, et al. Widespread cutaneous necrosis associated with antiphospholipid antibodies: report of four cases. J Clin Rheumatol. 2002;8:326–31.

    Article  PubMed  Google Scholar 

  36. Carlson JA, Chen KR. Cutaneous pseudovasculitis. Am J Dermatopathol. 2007;29:44–55.

    Article  PubMed  Google Scholar 

  37. Asherson RA, Cervera R, Shoenfeld Y. Peripheral vascular occlusions leading to gangrene and amputations in antiphospholipid antibody positive patients. Ann N Y Acad Sci. 2007;1108:515–29.

    Article  PubMed  CAS  Google Scholar 

  38. Asherson RA, Cervera R, Klumb E, et al. Amputation of digits or limbs in patients with antiphospholipid syndrome. Semin Arthritis Rheum. 2008;38:124–31.

    Article  PubMed  Google Scholar 

  39. Sparsa A, Piette JC, Wechsler B, et al. Anetoderma and its prothrombotic abnormalities. J Am Acad Dermatol. 2003;49:1008–12.

    Article  PubMed  Google Scholar 

  40. Hodak E, Shamai-Lubovitz O, David M, et al. Immunologic abnormalities associated with primary anetoderma. Arch Dermatol. 1992;128:799–803.

    Article  PubMed  CAS  Google Scholar 

  41. Hodak E, Feureman H, David M. Primary anetoderma is a cutaneous sign of antiphospholipid antibodies. J Am Acad Dermatol. 2008;58:351.

    Article  PubMed  Google Scholar 

  42. Pascual JC, Gimenez E, Sivera F, et al. Atrophic macules and soft papules in a 24-year-old woman. Anetoderma associated with antiphospholipid antibodies. Arch Dermatol. 2007;143:109–14.

    Article  PubMed  Google Scholar 

  43. Bilen N, Bayramgurler D, Sikar A, et al. Anetoderma associated with antiphospholipid syndrome and systemic lupus erythematosus. Lupus. 2003;12:714–6.

    Article  PubMed  CAS  Google Scholar 

  44. Katz SK, Mudd LJ, Roenigk Jr HH. Malignant atrophic papulosis (Degos’ disease) involving three generations of a family. J Am Acad Dermatol. 1997;37:480–4.

    Article  PubMed  CAS  Google Scholar 

  45. Uthman IW, Khamashta MA. Livedo racemosa: a striking dermatological sign for the antiphospholipid syndrome. J Rheumatol. 2006;33:2379–82.

    PubMed  Google Scholar 

  46. Romani J, Perez F, Llobet M, et al. Anetoderma associated with antiphospholipid antibodies: case report and review of the literature. J Eur Acad Dermatol Venereol. 2001;15:175–8.

    Article  PubMed  CAS  Google Scholar 

  47. Venhoff N, Miehle N, Juttner E, et al. Clinical images: anetoderma in systemic lupus erythematosus with antiphospholipid antibodies. Arthritis Rheum. 2005;52:2228.

    Article  PubMed  CAS  Google Scholar 

  48. Cervera R, Tektonidou MG, Espinosa G, et al. Task force on catastrophic antiphospholipid syndrome (APS) and non-criteria APS manifestations (II): thrombocytopenia and skin manifestations. Lupus. 2011;20:174–81.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The members of the “Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations” that contributed to the discussions that are presented in this chapter are as follows:

Ricard Cervera and Gerard Espinosa (Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Catalonia, Spain), Maria G. Tektonidou (First Department of Internal Medicine, Medical School, National University of Athens, Athens, Greece), Antonio R. Cabral (Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico), Emilio B. González (Division of Rheumatology, Department of Medicine, The University of Texas Medical Branch, Galveston, Texas, USA), Doruk Erkan (The Barbara Volcker Center for Women and Rheumatic Disease, Hospital for Special Surgery, Weill Medical College of Cornell University, New York, NY, USA), Smita Vaidya (Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA), Horacio E. Adrogué (The Methodist Hospital Transplant Center, Fannin, Houston, Texas, USA), Michal Solomon (Department of Dermatology, Chaim Sheba Medical Center, Tel Hashomer, Israel), Gisele Zandman-Goddard (Department of Medicine C, Wolfson Medical Center, Tel Hashomer, Israel), and Yehuda Shoenfeld (Zublodovitz Center for Autoimmune Diseases and Department of Medicine B, Chaim Sheba Medical Center, Tel Hashomer, Israel).

Author information

Authors and Affiliations

  1. Department of Dermatology, Sheba Medical Center, Ramat-Gan, Israel

    Michal Solomon MD

  2. Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Ramat-Gan, Israel

    Yehuda Shoenfeld MD

  3. Department of Medicine C, Wolfson Medical Center, 61 Halochamim Street, 63, Holon, 58100, Israel

    Gisele Zandman-Goddard PhD

Authors
  1. Michal Solomon MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yehuda Shoenfeld MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gisele Zandman-Goddard PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gisele Zandman-Goddard PhD .

Editor information

Editors and Affiliations

  1. The Barbara Volcker Center for Women and Rheumatic Diseases, Hospital for Special Surgery, New York, NY, USA

    Doruk Erkan

  2. University of Texas Medical Branch, 301 University Boulevard, Galveston, 77555-0883, Texas, USA

    Silvia S. Pierangeli

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Solomon, M., Shoenfeld, Y., Zandman-Goddard, G. (2012). Task Force Report on Non-criteria Manifestations: Skin. In: Erkan, D., Pierangeli, S. (eds) Antiphospholipid Syndrome. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-3194-7_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-3194-7_16

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4614-3193-0

  • Online ISBN: 978-1-4614-3194-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation